187 related articles for article (PubMed ID: 8405744)
21. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.
Vinci C; Caltabiano V; Santoro AM; Rabuazzo AM; Buscema M; Purrello R; Rizzarelli E; Vigneri R; Purrello F
Diabetologia; 1995 Jan; 38(1):39-45. PubMed ID: 7744228
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1.
Sandler S; Welsh N
Biochem Biophys Res Commun; 1993 Sep; 195(2):859-65. PubMed ID: 8373422
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta.
Helqvist S; Polla BS; Johannesen J; Nerup J
Diabetologia; 1991 Mar; 34(3):150-6. PubMed ID: 1884886
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.
Southern C; Schulster D; Green IC
Biochem J; 1990 Nov; 272(1):243-5. PubMed ID: 2264829
[TBL] [Abstract][Full Text] [Related]
26. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats.
Wogensen LD; Reimers J; Nerup J; Kolb-Bachofen V; Kröncke KD; Almdal T; Mandrup-Poulsen T
Diabetologia; 1992 Apr; 35(4):331-9. PubMed ID: 1516761
[TBL] [Abstract][Full Text] [Related]
27. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
28. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
Comens PG; Wolf BA; Unanue ER; Lacy PE; McDaniel ML
Diabetes; 1987 Aug; 36(8):963-70. PubMed ID: 3297891
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells.
Hao W; Palmer JP
J Interferon Cytokine Res; 1995 Dec; 15(12):1075-81. PubMed ID: 8746789
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 beta induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis.
Eizirik DL
Autoimmunity; 1991; 10(2):107-13. PubMed ID: 1782324
[TBL] [Abstract][Full Text] [Related]
32. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
33. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets.
Welsh N; Sandler S
Biochem Biophys Res Commun; 1992 Jan; 182(1):333-40. PubMed ID: 1731791
[TBL] [Abstract][Full Text] [Related]
35. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets.
Hughes JH; Easom RA; Wolf BA; Turk J; McDaniel ML
Diabetes; 1989 Oct; 38(10):1251-7. PubMed ID: 2507377
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1 beta.
Reddy S; Salari-Lak N; Sandler S
Endocrinology; 1995 May; 136(5):1907-12. PubMed ID: 7720637
[TBL] [Abstract][Full Text] [Related]
38. Effect of recombinant IL-1 isomers on fetal and adult islet cell function and replication.
Khatim MS; Bahr GM; Gumaa KA; Behbehani K
Diabetes Res; 1988 May; 8(1):25-9. PubMed ID: 3066563
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets.
Borg LA; Cagliero E; Sandler S; Welsh N; Eizirik DL
Endocrinology; 1992 May; 130(5):2851-7. PubMed ID: 1533363
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
Sjöholm A
FEBS Lett; 1991 Sep; 289(2):249-52. PubMed ID: 1655527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
